Skip to content

A study to evaluate the safety and efficacy of using dexmedetomidine ( a sedative agent) in mechanically ventilated children( children breathing via tube) during planned liberation from mechanical ventilation

Peri- extubation dexmedetomidine infusion in mechanically ventilated young children - A Pilot randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099953
Enrollment
50
Registered
2025-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J969- Respiratory failure, unspecified

Interventions

Intervention1: Dexmedetomidine: children randomized to this arm will be started on dexmedetomidine ( a sedo- analgesic agent) infusion @ 0.5mcg/kg/hour (@1ml/hour) , starting 4 to 12 hours prior to pl

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. mechanically ventilated for more than 48 hours 2. planned for extubation in next 12 to 24 hours

Exclusion criteria

Exclusion criteria: 1. Use of dexmedetomidine or clonidine within 12 hours prior to enrollment 2. Extubation for withdrawal of life support 3. Cardiovascular instability manifested by - a. Mean arterial BP less than 5th centile for air despite adequate fluid and vasopressor resuscitation 4. Pateints having 2nd or 3rd degree heart block

Design outcomes

Primary

MeasureTime frame
1. successful extubation ( defined as - Pateint free from invasive mechanical ventilation for 48 hours following extubation) 2.Post extubation airway obstruction (defined as Wesley croup score more than/equal to 3 anytime in 24 hours following extubationTimepoint: 1. 48 hours following extubation 2. in 24 hours following extubation

Secondary

MeasureTime frame
Peri- extubation agitation ( defined as RASS (Richmond agitation- sedation scale) more than/equal to +1 )Timepoint: from initiation of drug to 24 hours post extubation;Recruitment rate ( defined as proportion of enrolled children amongst total eligible children) Timepoint: ;Protocol adherence ( Time from randomization to initiation of trial drug infusion to extubation Total duration of trial drug infusion Number and duration of trial drug interruptionsTimepoint: ;Accidental extubation ( defined as Candidates who undergo self extubation or accidental extubation before planned extubation)Timepoint: from intiation of drug infusion to extubation;Adverse drug effects( defined as Incidence of bradycardia (defined as heart rate less than 70)/ hypotension (defined as BPless than 5th centile for age)Timepoint: anytime during study period;sedation withdrawal ( defined as WAT score more than/equal to 3 )Timepoint: 48 hours post extubation

Countries

India

Contacts

Public ContactSushen Tandon

Post graduate institute of medical education and research

randhawams192@gmail.com9915627064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026